Latest Posts

  • Finance 0

    Swing Trading Watch-List – May 16, 2016

    Here’s your swing-trading watch-list: Short Trimble Navigation (TRMB) Short Gamestop (GME) Short Olin (OLN) Long Akorn (AKRX) Long Williams Cos (WMB)...
    On May 16, 2016 / By
  • Finance 0

    Frustrated With Economists

    What if the FOMC and the wider Federal Reserve apparatus had heeded Greenspan’s uncertainty? There is grave danger in wandering too far into counterfactuals, but there is some value, I think, in the exercise in this context. What we are really talking about is time, and it is time that is most relevant today as the greatest economic cost. This current economy, the one which follows from the FOMC contemptuously ignoring Greenspan, including the Chairman himself, has already surrendered trillions because of it. The Fed Chairman in June 2003 wondered quite pointedly whether monetary policy was as sharp as everyone at that table believed. Th...
    On May 16, 2016 / By
  • Finance 0

    LendingClubbed: Stock Plummets On News Of A DOJ Grand Jury Subpoena As Accusations Fly

    While it will hardly come as a shock following the turbulent events disclosed one week ago, which culminated with the “resignation” of CEO Renaud Laplanche, amid a series of complicated backdoor ‘related party’ transactions which could even implicate none other than company director and former Morgan Stanley CEO John Mack, moments ago LendingClub (LC) unveiled in its 10-Q filing that “on May 9, 2016, following the announcement of the board review described elsewhere in this filing, the Company received a grand jury subpoena from the U.S. Department of Justice (DOJ). The Company also contacted the SEC. The Company...
    On May 16, 2016 / By
  • Finance 0

    E Aduro Biotech Fails Phase 2 Pancreatic Cancer; Shares Fall 16%

    Shares of Aduro Biotech (ADRO) tanked by 16.65% today after the company announced that it had failed its phase 2b “Eclipse” trial in patients with pancreatic cancer. The phase 2b trial was testing the company’s vaccine immunotherapy CRS-207, which is the company’s most advanced drug in the pipeline. For the phase 2b trial the company was testing their drug either alone or in combination with another drug, GVAX Pancreas, against chemotherapy.  The final results was that CRS-207 and GVAX Pancreas obtained a medial overall survival of 3.8 months, while CRS-207 alone performed better with an overall survival of 5.4 months...
    On May 16, 2016 / By
  • Finance 0

    Precious Metal Report – May 16, 2016

    Ira Epstein leads us through the day’s precious metal highlights.  (Video length 00:07:03)...
    On May 16, 2016 / By
  • Finance 0

    5 Tech Stocks To Buck The Sector’s Downtrend

    Technology stocks may no longer be the preferred option for U.S. investors. Over the last month, the Technology Sector SPDR (XLK) has become the highest decliner among the S&P 500 sectors, losing 5.2%. Additionally, the sector is down 1.5% year to date. Poor earnings results have been the nemesis for S&P 500’s largest sector this year. But that doesn’t mean that stocks which make up nearly a fifth of the benchmark can be ignored outright. Most of the disappointment has stemmed from the earnings of behemoths whose impact overshadowed several smaller and better performers. This is why it makes sense to pick such tech stocks from the...
    On May 16, 2016 / By
  • Finance 0

    Bulls Recover Indices 50-day MAs

    Bulls were able to press their advantage with good relative gains. Buyers were able to recover 50-day MAs and take indices back from the brink. In addition to a close above the 50-day MA, the Dow did enough to generate a ‘bear trap’ – next up will be to break declining resistance from the high. Technicals edge in favour of bears and overall volume hasn’t been great either, but because of such conditions, today’s buying was harder to achieve. The Russell 2000 also made it back above its 50-day MA, but finished on its 200-day MA which is also below the rising channel. It’s a harder sell for bulls, but I do ha...
    On May 16, 2016 / By
  • Finance 0

    REITs Continue To Fly Under The Radar

    Real estate investment trusts (REITs) represent a type of security that invests in real estate, through either property or mortgages, and typically trade on an exchange. While many concerns have been raised about non-traded REITs in recent years, publicly traded REITs, both in the U.S. and globally, have turned in some impressive results of late. Consider the performance of two of the better known indexes that track U.S. and global REITs over the past year and thus far in 2016. Source: Wells Fargo Advisors as of May 3, 2016. Index performance is total return performance which includes gains and losses plus income unless otherwise noted. You ...
    On May 16, 2016 / By
  • Finance 0

    S&P 500 Snapshot: A Strong Start To The Week

    The S&P 500 rallied at the open, rose steadily through the morning, hovered in a narrow range for a couple of hours and the surged to its 1.23% intraday high at the start of the final hour of trading. Some profit taking in that final hour reduced the closing gain to a healthy 0.98%. Today’s optimism was apparently influenced by Apple’s substantial 3.71% bounce on reports that Warren Buffett’s Berkshire Hathaway bought a stake in the company. Nevertheless, Apple remains 16.3% below its YTD high in April). US equities also took a positive view of a similar bounce in oil. West Texas Intermediate Crude ended the day up 2.96% per...
    On May 16, 2016 / By
  • Finance 0

    Head & Shoulders Still Points To Lower

    “If you want to have a better performance than the crowd, you must do things differently from the crowd.”  John Templeton Another day with not too much going on as markets and stocks are not showing any trend at all yet. AAPL saw a nice spike on news that Warren Buffet bought a $1 billion stake in the company. He is usually into safer, steady stocks who don’t move fast often so that plays into my views that the stock has long since had it’s glory days. I shorted some TSLA today but that’s all I’ve got for positions at the moment. SPY had a nice day until weakness into the close as it continues to setup for a move lower. The head ...
    On May 16, 2016 / By